These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35937263)

  • 1. "It's my frenemy": A qualitative exploration of knowledge and perceptions of fentanyl use during the COVID-19 pandemic in people who use drugs at a syringe services program in Philadelphia, PA.
    Bass SB; Kelly PJA; Pandit-Kerr S; Pilla J; Morris K; Larsen E; Wisdom JP; Torralva PR
    Front Public Health; 2022; 10():882421. PubMed ID: 35937263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings.
    Bolinski RS; Walters S; Salisbury-Afshar E; Ouellet LJ; Jenkins WD; Almirol E; Van Ham B; Fletcher S; Johnson C; Schneider JA; Ompad D; Pho MT
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "I probably got a minute": Perceptions of fentanyl test strip use among people who use stimulants.
    Reed MK; Roth AM; Tabb LP; Groves AK; Lankenau SE
    Int J Drug Policy; 2021 Jun; 92():103147. PubMed ID: 33583679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study.
    Goldman JE; Waye KM; Periera KA; Krieger MS; Yedinak JL; Marshall BDL
    Harm Reduct J; 2019 Jan; 16(1):3. PubMed ID: 30621699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "You can't go wrong being safe": Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs.
    Reed MK; Guth A; Salcedo VJ; Hom JK; Rising KL
    Int J Drug Policy; 2022 May; 103():103643. PubMed ID: 35255392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs.
    Reed MK; Salcedo VJ; Guth A; Rising KL
    J Subst Abuse Treat; 2022 Sep; 140():108790. PubMed ID: 35577663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fentanyl Exposure and Detection Strategies Utilized by Clinical Trial Participants Seeking Linkage to Opioid Use Disorder Treatment at a Syringe Service Program.
    Watson DP; Ray B; Phalen P; Duhart Clarke SE; Taylor L; Swartz J; Gastala N
    J Med Toxicol; 2024 Jan; 20(1):13-21. PubMed ID: 38048033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "It's probably going to save my life;" attitudes towards treatment among people incarcerated in the era of fentanyl.
    Kaplowitz E; Macmadu A; Green TC; Berk J; Rich JD; Brinkley-Rubinstein L
    Drug Alcohol Depend; 2022 Mar; 232():109325. PubMed ID: 35114617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Being "hooked up" during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City.
    McKnight C; Des Jarlais DC
    Int J Drug Policy; 2018 Oct; 60():82-88. PubMed ID: 30176422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City.
    Beharie N; Urmanche A; Harocopos A
    Harm Reduct J; 2023 Mar; 20(1):38. PubMed ID: 36966342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking.
    Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R
    Harm Reduct J; 2023 Mar; 20(1):41. PubMed ID: 36978170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "You can see those concentric rings going out": Emergency personnel's experiences treating overdose and perspectives on policy-level responses to the opioid crisis in New Hampshire.
    Saunders E; Metcalf SA; Walsh O; Moore SK; Meier A; McLeman B; Auty S; Bessen S; Marsch LA
    Drug Alcohol Depend; 2019 Nov; 204():107555. PubMed ID: 31542630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
    Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL
    Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing risks of women and men who use fentanyl: "The number one thing I worry about would be my safety and number two would be overdose".
    Harris MTH; Bagley SM; Maschke A; Schoenberger SF; Sampath S; Walley AY; Gunn CM
    J Subst Abuse Treat; 2021 Jun; 125():108313. PubMed ID: 34016300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-based preferences for risk communication in the fentanyl era: 'A lot of people keep seeing other people die and that's not enough for them'.
    Gunn CM; Maschke A; Harris M; Schoenberger SF; Sampath S; Walley AY; Bagley SM
    Addiction; 2021 Jun; 116(6):1495-1504. PubMed ID: 33119196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urban, individuals of color are impacted by fentanyl-contaminated heroin.
    Rhodes B; Costenbader B; Wilson L; Hershow R; Carroll J; Zule W; Golin C; Brinkley-Rubinstein L
    Int J Drug Policy; 2019 Nov; 73():1-6. PubMed ID: 31330274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study assessing client understanding and use of fentanyl test strips for harm reduction.
    Barrolle AA; Gable KN; Dell N
    J Am Pharm Assoc (2003); 2023; 63(1):295-300. PubMed ID: 36280433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge, attitudes, and behaviors related to the fentanyl-adulterated drug supply among people who use drugs in Oregon.
    LaForge K; Stack E; Shin S; Pope J; Larsen JE; Leichtling G; Leahy JM; Seaman A; Hoover D; Byers M; Barrie C; Chisholm L; Korthuis PT
    J Subst Abuse Treat; 2022 Oct; 141():108849. PubMed ID: 35932759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.